Hwang Woo-suk's new pet project

Disgraced South Korean stem cell researcher Hwang Woo-suk has set up a biotechnology firm in Seoul for cloning animal pets and producing organs for transplant, according to Agence France Presse. Hwang was banned from research using human eggs following claims that he cloned the first human embryo that were later shown to be faked. He is currently on trial for fraud, embezzlement, ethical breaches and other charges, but is not barred from conducting research on animals. Still, Hwang insists his

Written byElie Dolgin
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Disgraced South Korean stem cell researcher Hwang Woo-suk has set up a biotechnology firm in Seoul for cloning animal pets and producing organs for transplant, according to Agence France Presse. Hwang was banned from research using human eggs following claims that he cloned the first human embryo that were later shown to be faked. He is currently on trial for fraud, embezzlement, ethical breaches and other charges, but is not barred from conducting research on animals. Still, Hwang insists his cloned human stem cells were legit, and he has also asked the government's Health Ministry for permission to resume research into human cloning in order to clear his name, a close associate of Hwang's told the AFP. In 2005, Hwang's former colleagues at Seoul National University, led by Lee Byeong-chun, a key aide to Hwang, created the world's first dog clone -- an Afghan hound named "Snuppy." Last month, Lee announced that Snuppy had successfully impregnated two female hounds and would become a father later this month, and Korean Customs Service unveiled seven cloned Labrador retrievers being trained as sniffer dogs to detect drugs and explosives.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo